Drug Farm Completes First Closing Of $55 Million Series D Financing
By Amit Chowdhry ● Jul 13, 2026
Drug Farm announced the successful first closing of its $55 million Series D financing to advance its clinical and preclinical development pipeline. The round was co-led by Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collaborative Private Equity Fund Partnership Enterprise. New investors in the financing included Tukar Capital, Fuzhou Xinhe Fund, Shenzhen Luohu Donghai Chempartner Investment Fund, and Keyuan Pharma. Existing investors also participated, including BioVeda China Fund, YD Capital, Jiashan State VC, Detong Capital, Wedo Capital, and Biometas.